Ilse R Dubbelboer

6PUBLICATIONS
9CO-AUTHORS
Pharmaceutical delivery technologiesEnvironmentally sustainable engineeringToxicology (incl. clinical toxicology)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology Framework.

|Feb 18, 2026
Revival of Ethionamide by Alpibectir.

Michel Pieren, Glenn E Dale, Marc Gitzinger

|Jun 02, 2025
Pharmacokinetics of Amoxicillin in the Cat.

Ilse R Dubbelboer, Lena Olsén, Lena Pelander

|Sep 01, 2018
Porcine and Human In Vivo Simulations for Doxorubicin-Containing Formulations Used in Locoregional Hepatocellular Carcinoma Treatment.

Ilse R Dubbelboer, Erik Sjögren, Hans Lennernäs

|Nov 30, 2017
Reply to "Comment on 'In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma'".

Ilse R Dubbelboer, Elsa Lilienberg, Amar Karalli

|Feb 10, 2017
A Model-Based Approach To Assessing the Importance of Intracellular Binding Sites in Doxorubicin Disposition.

Ilse R Dubbelboer, Elsa Lilienberg, Erik Sjögren

Pageof 1

Frequent Collaborators

3 joint publications

Erik Sjögren

2 joint publications

Elsa Lilienberg

1 joint publications

Moriah Pellowe

1 joint publications

Lena Olsén